UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reportedly): April 4, 2005
OCEAN BIO-CHEM, INC.
(Exact name of registrant as specified in charter)
Florida 2-70197 59-1564329
(State or Other (Commission File Number) (I.R.S. Employer
Jurisdiction of Identification No.)
Incorporation)
4041 S.W. 47 Avenue, Fort Lauderdale, Florida 33314
(Address of principal executive office Zip Code)
(954) 587-6280
Registrant's telephone number, including area code:
Not Applicable
(Former name or former address, if changes since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 3.02 - Unregistered Sale of Equity Securities
On April 4, 2005, the Company's Board of Directors granted an aggregate of
122,000 shares of its common stock to twelve of its employee as bonuses for the
fiscal year ended December 31, 2004. The Company issued these shares to its
employees in reliance upon Section 4(2) of the Securities Act, because each of
them was knowledgeable, sophisticated and had access to comprehensive
information about the Company. The Company placed restrictive legends on the
certificates stating that the securities were not registered under the
Securities Act and set forth their restrictions on transferability and sale.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
April 4, 2005
Ocean Bio-Chem, Inc.
/s/ Peter G. Dornau
-------------------------
Peter G. Dornau
Chairman of the Board and
Chief Executive Officer